{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04151082",
            "orgStudyIdInfo": {
                "id": "2019-0207"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2019-06735",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "2019-0207",
                    "type": "OTHER",
                    "domain": "M D Anderson Cancer Center"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors",
            "officialTitle": "Stop LCNP: High Dose Steroid Therapy for Late Radiation-Associated Lower Cranial Neuropathy: A Phase I/II Dose Finding Trial and Data Registry",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "high-dose-steroid-therapy-prednisone-or-methylprednisolone-for-the-improvement-of-symptoms-of-late-radiation-associated-lower-cranial-neuropathy-in-oropharyngeal-cancer-survivors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-10-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-10-16",
            "studyFirstSubmitQcDate": "2019-11-01",
            "studyFirstPostDateStruct": {
                "date": "2019-11-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This phase I/II trial studies the side effect and best dose of steroid therapy (prednisone or methylprednisolone) in improving symptoms of late radiation-associated lower cranial neuropathy in oropharyngeal cancer survivors. Steroid therapy with prednisone or methylprednisolone may help to improve symptoms associated with late radiation-associated lower cranial neuropathy.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To establish feasibility and maximum tolerated dose (MTD) of steroid therapy that provides symptomatic improvement in oropharyngeal cancer (OPC) survivors with late lower cranial neuropathy (LCNP).\n\nSECONDARY OBJECTIVE:\n\nI. To examine endpoints that may be sensitive to functional or symptomatic gains with steroid therapy for late LCNP in OPC survivors by characterizing changes in symptoms, functional status, quality of life (QOL), neurophysiology, and imaging studies after steroid therapy.\n\nTERTIARY OBJECTIVE:\n\nI. To establish a hypothesis-generating database of physiologic, functional, and patient-reported outcomes (PROs) among head and neck cancer (HNC) survivors with late lower cranial neuropathy treated with steroid therapy.\n\nOUTLINE: This is a phase I, dose-escalation study of steroid therapy followed by a phase II study.\n\nPatients receive prednisone orally (PO) (or by feeding tube) once daily (QD) on days 1-5 and then taper off over 2 weeks or methylprednisolone intravenously (IV) over 1 hour on days 1-5 in the absence of disease progression or unacceptable toxicity."
        },
        "conditionsModule": {
            "conditions": [
                "Cranial Nerve Disorder",
                "Head and Neck Carcinoma",
                "Oropharyngeal Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 35,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Supportive care (steroid therapy)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive prednisone PO (or by feeding tube) QD on days 1-5 and then taper off over 2 weeks or methylprednisolone IV over 1 hour on days 1-5 in the absence of disease progression or unacceptable toxicity.",
                    "interventionNames": [
                        "Drug: Methylprednisolone",
                        "Drug: Prednisone",
                        "Other: Quality-of-Life Assessment",
                        "Other: Questionnaire Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Methylprednisolone",
                    "description": "Given IV",
                    "armGroupLabels": [
                        "Supportive care (steroid therapy)"
                    ],
                    "otherNames": [
                        "Adlone",
                        "Caberdelta M",
                        "DepMedalone",
                        "Depo Moderin",
                        "Depo-Nisolone",
                        "Duralone",
                        "Emmetipi",
                        "Esametone",
                        "Firmacort",
                        "Medlone 21",
                        "Medrate",
                        "Medrol",
                        "Medrol Veriderm",
                        "Medrone",
                        "Mega-Star",
                        "Meprolone",
                        "Methylprednisolonum",
                        "Metilbetasone Solubile",
                        "Metrocort",
                        "Metypresol",
                        "Metysolon",
                        "Predni-M-Tablinen",
                        "Prednilen",
                        "Radilem",
                        "Sieropresol",
                        "Solpredone",
                        "Summicort",
                        "Urbason",
                        "Veriderm Medrol",
                        "Wyacort"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Prednisone",
                    "description": "Given PO",
                    "armGroupLabels": [
                        "Supportive care (steroid therapy)"
                    ],
                    "otherNames": [
                        ".delta.1-Cortisone",
                        "1, 2-Dehydrocortisone",
                        "Adasone",
                        "Cortancyl",
                        "Dacortin",
                        "DeCortin",
                        "Decortisyl",
                        "Decorton",
                        "Delta 1-Cortisone",
                        "Delta-Dome",
                        "Deltacortene",
                        "Deltacortisone",
                        "Deltadehydrocortisone",
                        "Deltasone",
                        "Deltison",
                        "Deltra",
                        "Econosone",
                        "Lisacort",
                        "Meprosona-F",
                        "Metacortandracin",
                        "Meticorten",
                        "Ofisolona",
                        "Orasone",
                        "Panafcort",
                        "Panasol-S",
                        "Paracort",
                        "Perrigo Prednisone",
                        "PRED",
                        "Predicor",
                        "Predicorten",
                        "Prednicen-M",
                        "Prednicort",
                        "Prednidib",
                        "Prednilonga",
                        "Predniment",
                        "Prednisone Intensol",
                        "Prednisonum",
                        "Prednitone",
                        "Promifen",
                        "Rayos",
                        "Servisone",
                        "SK-Prednisone"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Quality-of-Life Assessment",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Supportive care (steroid therapy)"
                    ],
                    "otherNames": [
                        "Quality of Life Assessment"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Supportive care (steroid therapy)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum tolerated dose",
                    "timeFrame": "Up to 3 weeks"
                },
                {
                    "measure": "Change in MD Anderson Symptom Inventory - Head and Neck (MDASI-HN) top 5 mean",
                    "timeFrame": "Baseline up to 3 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Improvement in tongue innervation on electromyography (EMG) findings",
                    "description": "1. EMG scores are based on a 4-point denervation potentials grade with '0' being 'none' and '4' being 'full interference patterns of potentials'.\n2. Nerve conduction study (NCS) scores are based on a 4-point scale ranging from 'none' (best) to 'severely prolonged' or 'severely reduced' (worst).",
                    "timeFrame": "Up to 3 years"
                },
                {
                    "measure": "Improvement in dynamic imaging grade of swallowing toxicity (DIGEST) scores",
                    "description": "1. DIGEST scores are rated on a 0-4 scale from 0 (best) to 4 (worst).",
                    "timeFrame": "Up to 3 years"
                },
                {
                    "measure": "Changes in maximum isometric lingual strength (MILS) and lingual range of motion (LROM)",
                    "description": "1. MILS scores are rated on continuous scale from 0 (worst) to 100 (best).\n2. LROM scores are rated on an ordinal scale from 0 (worst) to 100 (best).",
                    "timeFrame": "Baseline up to 3 years"
                },
                {
                    "measure": "Changes in patient reported outcomes (PRO) on MD Anderson Dysphagia Inventory (MDADI), Performance Status Scale for Head and Neck (PSS-HN), or EuroQOL (EQ-5D)",
                    "description": "1. MDADI scores are rated on a continuous scale from 20 (worst) to 100 (best).\n2. Diet, eating, and speech subscales of PSS-HN are rated on an ordinal scale from 0 (worst) to 100 (best).\n3. EQ-5D is rated on a continuous scale from 0 (worst) to 100 (best).",
                    "timeFrame": "Baseline up to 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* INCLUSION CRITERIA FOR CLINICAL TRIAL: Disease free adult survivors of oropharyngeal cancer\n* INCLUSION CRITERIA FOR CLINICAL TRIAL: Treated with radiotherapy \\>= 2 years post treatment (disease status per surveillance imaging and clinical surveillance)\n* INCLUSION CRITERIA FOR CLINICAL TRIAL: Late radiation-associated lower cranial neuropathy of XII with or without X nerve (LCNP cases will be considered therapy-related when imaging, physical examination, and/or biopsy fail to demonstrate structural or malignant source)\n* INCLUSION CRITERIA FOR CLINICAL TRIAL: Willing and able to return for assessment post-steroid therapy\n* INCLUSION CRITERIA FOR CLINICAL TRIAL: Able to complete symptom survey (MD Anderson Symptom Inventory - Head and Neck \\[MDASI-HN\\]) in validated languages: English, simplified Chinese, Filipino, Greek, Japanese, Korean, Russian, Spanish, Taiwanese\n* INCLUSION CRITERIA FOR REGISTRY: Disease-free adult survivors of head and neck cancer\n* INCLUSION CRITERIA FOR REGISTRY: \\>= 2 years post treatment (disease status per surveillance imaging and clinical surveillance)\n* INCLUSION CRITERIA FOR REGISTRY: Late lower cranial neuropathy of XII with or without X nerve (LCNP cases will be considered therapy-related when imaging, physical examination, and/or biopsy fail to demonstrate structural or malignant source)\n* INCLUSION CRITERIA FOR REGISTRY: Able to complete symptom survey (MDASI-HN) in validated languages: English, simplified Chinese, Filipino, Greek, Japanese, Korean, Russian, Spanish, Taiwanese\n\nExclusion Criteria:\n\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: Uncontrolled diabetes\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: Uncontrolled hypertension (systolic \\> 160; diastolic \\> 90)\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: Known gastrointestinal ulcer\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: History of psychosis\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: Pregnant women\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: Untreated or treatment refractory obstructive pharyngoesophageal stricture\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: Known history or diagnosis of bipolar disorder\n* EXCLUSION CRITERIA FOR CLINICAL TRIAL: History of surgery near hypoglossal nerve path\n* EXCLUSION CRITERIA FOR REGISTRY: Uncontrolled diabetes\n* EXCLUSION CRITERIA FOR REGISTRY: Uncontrolled hypertension (systolic \\> 160; diastolic \\> 90)\n* EXCLUSION CRITERIA FOR REGISTRY: Known gastrointestinal ulcer\n* EXCLUSION CRITERIA FOR REGISTRY: History of psychosis\n* EXCLUSION CRITERIA FOR REGISTRY: Pregnant women\n* EXCLUSION CRITERIA FOR REGISTRY: Untreated or treatment refractory obstructive pharyngoesophageal stricture\n* EXCLUSION CRITERIA FOR REGISTRY: Known history or diagnosis of bipolar disorder",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Katherine A Hutcheson",
                    "role": "CONTACT",
                    "phone": "713-792-6513",
                    "email": "karnold@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Katherine A Hutcheson",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Katherine A. Hutcheson, MD",
                            "role": "CONTACT",
                            "phone": "713-792-6920",
                            "email": "karnold@mdanderson.org"
                        },
                        {
                            "name": "Katherine A. Hutcheson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "MD Anderson Cancer Center Website",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000003389",
                    "term": "Cranial Nerve Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6605",
                    "name": "Cranial Nerve Diseases",
                    "asFound": "Cranial Nerve Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011241",
                    "term": "Prednisone"
                },
                {
                    "id": "D000008775",
                    "term": "Methylprednisolone"
                },
                {
                    "id": "D000077555",
                    "term": "Methylprednisolone Acetate"
                },
                {
                    "id": "D000008776",
                    "term": "Methylprednisolone Hemisuccinate"
                },
                {
                    "id": "D000011239",
                    "term": "Prednisolone"
                },
                {
                    "id": "C000009935",
                    "term": "Prednisolone acetate"
                },
                {
                    "id": "D000003348",
                    "term": "Cortisone"
                },
                {
                    "id": "C000021322",
                    "term": "Prednisolone hemisuccinate"
                },
                {
                    "id": "C000009022",
                    "term": "Prednisolone phosphate"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000018696",
                    "term": "Neuroprotective Agents"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14121",
                    "name": "Prednisone",
                    "asFound": "Prospective",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11749",
                    "name": "Methylprednisolone",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1833",
                    "name": "Methylprednisolone Acetate",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11750",
                    "name": "Methylprednisolone Hemisuccinate",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14120",
                    "name": "Prednisolone",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M229449",
                    "name": "Prednisolone acetate",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M211887",
                    "name": "Prednisolone hemisuccinate",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M248881",
                    "name": "Prednisolone phosphate",
                    "asFound": "Known",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6569",
                    "name": "Cortisone",
                    "asFound": "Clinical Evaluation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20773",
                    "name": "Neuroprotective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "NeuroAg",
                    "name": "Neuroprotective Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}